Free guide

Ozempic vs Wegovy vs Zepbound: Price Comparison

Ozempic (semaglutide) is FDA-approved for type 2 diabetes; Wegovy is FDA-approved semaglutide for chronic weight management; Zepbound is FDA-approved tirzepatide for chronic weight management. Self-pay prices differ by program, dose, and access channel, and are not interchangeable prescriptions.

Couple talking at a kitchen table, for a sexual health conversation checklist. Ozempic vs Wegovy vs Zepbound: Price Comparison.
  1. 1

    Read

    Start with the short answer.

  2. 2

    Prepare

    Take a question from the research.

  3. 3

    Speak

    Bring it to a physician.

Feel Ready

For your visit

Speak to a physician

Feel Ready visits are not open yet. These questions are ready for a physician you already see.

Written by Feel Ready Editorial Team

Last updated November 2026

Brand names are not interchangeable

Ozempic, Wegovy, and Zepbound contain different approved indications and dosing schedules even when they share an active ingredient class. A clinician chooses based on diagnosis, benefits, risks, and coverage—not on which name appears in an ad.

Compounded semaglutide or tirzepatide should not be marketed to consumers as Ozempic or Zepbound.

Advertised self-pay price snapshots

As of November 7, 2026, manufacturer-linked self-pay programs have publicly listed Wegovy near $199 for introductory periods then higher ongoing monthly rates, Ozempic self-pay often in a similar headline range depending on dose, and Zepbound often advertised from about $299 upward. Lilly and Novo programs change terms frequently.

Insurance, coupons, and employer benefits may differ from self-pay rates.

Why this matters for online care shoppers

Telehealth platforms increasingly route patients to FDA-approved medicines at manufacturer self-pay prices rather than compounded copies. Compare total care cost—consult access, follow-up, and fulfillment—not only the medicine line item.

Compounded semaglutide and tirzepatide are not the same products as FDA-approved Ozempic, Wegovy, or Zepbound. Compounding availability depends on patient-specific clinical need and applicable federal and state rules. The FDA has tightened routine compounding of copies now that approved products are commercially available.

MedicineActive ingredientTypical FDA-approved useSelf-pay notes (2026 ads)
OzempicSemaglutideType 2 diabetesNot a weight-brand label; price varies by dose
WegovySemaglutideChronic weight managementIntro offers often ~$199, then higher
ZepboundTirzepatideChronic weight managementOften from ~$299 with conditions

Sources

What to ask a physician

These checked public sources are the background for this guide. They do not diagnose you, and they do not tell a physician what to prescribe.

Related guides

Curious about what comes next?

Join the waitlist. When clinician-guided care opens in your state, Feel Ready will contact you about a private consultation. There is no treatment or payment today.

Join the Waitlist